CTLA4 and melanoma: This is in line with our own observations of the induction of systemic and protective anti-melanoma immunity in early-stage melanoma through local immune modulation of the SLN after surgical removal of the primary tumor, either by CpG-B (44) or by anti-CTLA-4 (71).